IMPLEMENTATION LEVEL

National

AFFECTED FLOW

Inflow

ANNOUNCED AS TEMPORARY

No

NON-TRADE-RELATED RATIONALE

No

ELIGIBLE FIRMS

all

JUMBO

No

TARIFF PEAK

No
← back to the state act
Inception date: 23 Apr 2015 | Removal date: open ended
Still in force

Tax or social insurance relief

On April 23, 2015, the South African National Treasury published under Government Gazette No. 38732 a new tax incentive for pharmaceutical companies performing R&D or clinical trials within South Africa's borders. Such tax deductions may amount to up to 150% of the cost of the R&D operations (amounts above 100% allow to offset future taxable income).

This law comes in the form of an amendment to South Africa's Income Tax Act of 1962 in where it allowed other companies performing R&D operations in South Africa to receive up to 150% of deductions in taxes. Such projects must be preapproved by South Africa's Department of Science and Technology.

AFFECTED COUNTRIES

MAP
TABLE
EXPORT

AFFECTED SECTORS AND PRODUCTS

352 Pharmaceutical products

Please report this page in case you detect an inaccuracy in its content.